Danielle Campbell
Personalreferent bei ATYR PHARMA, INC.
Profil
Danielle Campbell's current job is Vice President-Human Resources at aTyr Pharma, Inc. Ms. Campbell's former jobs include Senior Director-Facilities Operations at Poseida Therapeutics, Inc. from 2019 to 2021, Manager-Human Resources at Celladon Corp.
from 2014 to 2015, and Human Resources Manager at aTyr Pharma, Inc. from 2015 to 2016.
She also worked as Manager-Human Resources & Equity Plans at Cytori Therapeutics, Inc. from 2008 to 2014.
Ms. Campbell obtained her undergraduate degree from the University of California, Irvine.
Aktive Positionen von Danielle Campbell
| Unternehmen | Position | Beginn |
|---|---|---|
| ATYR PHARMA, INC. | Personalreferent | 24.12.2021 |
Ehemalige bekannte Positionen von Danielle Campbell
| Unternehmen | Position | Ende |
|---|---|---|
| POSEIDA THERAPEUTICS, INC. | Personalreferent | 01.01.2019 |
| ATYR PHARMA, INC. | Personalreferent | 01.06.2016 |
Celladon Corp.
 Celladon Corp. BiotechnologyHealth Technology Celladon Corp. is a clinical-stage biotechnology company, engaging in the development of cardiovascular gene therapy. The company's therapeutic portfolio for diseases characterized by SERCA enzyme deficiency includes both gene therapies and small molecule compounds. Its most advanced product candidate MYDICAR uses gene therapy to target SERCA2a, an enzyme that is deficient in heart failure patients. Celladon was founded by Roger J. Hajjar and Kenneth R. Chien on December 21, 2000 and is headquartered in San Diego, CA. | Personalreferent | 01.11.2015 |
Cytori Therapeutics, Inc.
 Cytori Therapeutics, Inc. BiotechnologyHealth Technology Cytori Therapeutics, Inc. develops treatments and devices for cell therapy. The private company is based in San Diego, CA. | Personalreferent | 01.09.2014 |
Ausbildung von Danielle Campbell
| University of California, Irvine | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ATYR PHARMA, INC. | Health Technology |
| POSEIDA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Celladon Corp.
Celladon Corp. BiotechnologyHealth Technology Celladon Corp. is a clinical-stage biotechnology company, engaging in the development of cardiovascular gene therapy. The company's therapeutic portfolio for diseases characterized by SERCA enzyme deficiency includes both gene therapies and small molecule compounds. Its most advanced product candidate MYDICAR uses gene therapy to target SERCA2a, an enzyme that is deficient in heart failure patients. Celladon was founded by Roger J. Hajjar and Kenneth R. Chien on December 21, 2000 and is headquartered in San Diego, CA. | Health Technology |
Cytori Therapeutics, Inc.
Cytori Therapeutics, Inc. BiotechnologyHealth Technology Cytori Therapeutics, Inc. develops treatments and devices for cell therapy. The private company is based in San Diego, CA. | Health Technology |
